38th General Thoracis Surgical Club Annual Meeting

The purpose of this meeting is to provide a forum for general thoracic surgeons to learn the most up to date information on research, patient care, pathophysiology, surgical techniques and educational methods to maintain the optimum surgical care of general thoracic patients. This activity is designed to facilitate improved competence, performance-in-practice and patient outcomes.

Target Audience

This symposium is designed for an audience of physicians, physician assistants and other healthcare providers who practice thoracic surgery.

Learning Objectives

Ginsberg day -Keynote - Lots of Groups, Lots of Trials: What's Next?    

  • Identify the most promising avenues of clinical trial investigation in the thoracic surgery space.

The Role of Thoracic Surgeons in Prescribing Targeted Agents & Focused Review of Cooperative Group Trials

  • Identify current and pending clinical trials activated through the cooperative group mechanism and evaluate trial accrual progress using provided updates and data.

Important Papers in Thoracic Surgery 2025    

  • Review and critically analyze landmark papers published in 2025 that are relevant to thoracic surgery practice, as demonstrated by their ability to summarize key findings and implications for practice.
  • Apply newly acquired knowledge to real-world thoracic surgery cases. 
  • Demonstrate adherence to evidence-based surgical best practices. 
  • Evaluate changes in surgical performance and patient outcomes using case studies and outcome data.

Summary /Review of Empty Spaces/Panel Discussion    

  • Summarize existing trials.
  • Identify areas where new ideas and initiatives are needed.

GTSC Annual Meeting
Lung Cancer Updates

  • Describe current strategies for diagnosing and managing ground glass opacity-dominant lung adenocarcinoma, including surgical and non-surgical approaches.
  • Evaluate emerging treatments and multidisciplinary approaches in lung cancer care, including lung transplantation considerations and advanced management of Pancoast tumors.

There Is No Debate

  • Compare and contrast surgical approaches for chest wall and gastroesophageal conditions, including Nuss versus Ravitch procedures and gastropexy versus fundoplication, with emphasis on indications, outcomes, and patient selection.
  • Identify appropriate databases for thoracic surgery research and quality assessment, including the strengths and limitations of STS, AATS, and other relevant registries.

GTSC Surgical Movie Night

  • Explain the technical aspects of various general thoracic surgical procedures and actively engage in discussions on surgical decision-making and techniques.
  • Demonstrate enhanced competence by applying best practices in thoracic surgery, improve performance in clinical procedures, and implement strategies that lead to measurable improvements in patient outcomes.

Abstracts

  • Summarize and present key findings from new research in thoracic surgery.
  • Demonstrate improved competence by applying evidence-based practices in thoracic surgery, enhance performance in clinical decision-making, and implement strategies that lead to measurable improvements in patient outcomes.

Robotic Bronchoscopy Updates and Preparing the Next Generation of Leaders in Our Specialty

  • Assess the comparative effectiveness and safety of robotic bronchoscopic biopsy versus CT-guided biopsy and outline practical steps for implementing robotic bronchoscopy in clinical practice.
  • Review AI-driven methods for evaluating trainees and surgeons and discuss strategies to ensure the future competency and sustainability of the thoracic surgery specialty.

Super Bowl of X-Rays

  • Analyze unusual radiographic findings and determine accurate diagnoses and treatment plans through a case-based, team-based competition.
  • Apply diagnostic reasoning skills to enhance clinical competence, improve performance in practice, and contribute to better patient outcomes. 
Course summary
Available credit: 
  • 12.25 AAPA Category 1 CME
  • 12.25 AMA PRA Category 1 Credit
  • 12.25 Attendance
Course opens: 
03/12/2026
Course expires: 
04/12/2026
Cost:
$0.00
Rating: 
0
March 12-14, 2026 Course Location: Waimea, HI
Waimea, HI
United States

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

All of the relevant financial relationships listed for these individuals have been mitigated.

Author, Writer(s)

Hugh Auchincloss

has no relevant financial relationships to disclose at this time.

Haiquan Chen, MD. PhD.

has no relevant financial relationships to disclose at this time.

Erin Gillaspie

has a financial relationship (Speaker) with BMS;.
has a financial relationship (Advisor) with Astra Zeneca;.
has a financial relationship (Advisor) with BMS;.
has a financial relationship (Advisor) with Intuitive Surgical;.
has a financial relationship (Advisor) with Genentech;.
has a financial relationship (Advisor) with Daiichi Sankyo;.
has a financial relationship (Advisor) with Merck;.
has a financial relationship (Speaker) with Astra Zeneca;.

Erin Hoover, MD

has no relevant financial relationships to disclose at this time.

Dawn Jaroszewski, MD, MBA, FACS

has a financial relationship (Consultant) with Zimmer Biomet Inc;.
has a financial relationship (Royalties or patent beneficiary) with Zimmer Biomet Inc;.
has a financial relationship (Speaker) with Atricure, Inc;.

Siva Raja, MD, PhD

has no relevant financial relationships to disclose at this time.

Daniel Raymond, MD, FACS, FACCP

has a financial relationship (Consultant) with KLS Martin;.
has a financial relationship (Individual stocks and stock options) with Bristol Myers Squibb;.
has a financial relationship (Individual stocks and stock options) with Zimmer Biomet;.

Rishindra Reddy, MD, MBA

has a financial relationship (Consultant) with Inuitive Surgical;.
has a financial relationship (Advisor) with On Target Labs;.
has a financial relationship (Advisor) with Medtronic;.
has a financial relationship (Advisor) with Atricure;.
has a financial relationship (Advisor) with J&J;.
has a financial relationship (Advisor) with Genentech;.
has a financial relationship (Consultant) with BMS;.
has a financial relationship (Advisor) with AZ;.

James Reinersman, MD

has a financial relationship (Speaker) with Intuitive Surgical;.

Valerie Rusch, M.D.

has a financial relationship (Consultant) with American College of Surgeons;.

Sahar Saddoughi, M.D., Ph.D

has no relevant financial relationships to disclose at this time.

Christopher Seder, MD

has no relevant financial relationships to disclose at this time.

Dennis Wigle, MD

has no relevant financial relationships to disclose at this time.

Stephanie Worrell

has no relevant financial relationships to disclose at this time.

Stephen Yang, The Arthur B. and Patricia B. Modell Endowed Chair of Thoracic Surgery Vice Chair of Professional Development, Department of Surgery Professor of Surgery and Oncology The Johns Hopkins Medical Institutions Examination Chair Emeritus, and SESATS XIII Edito

has a financial relationship (Consultant) with ABTS;.

Crystal Zhang, MD, MPH

has no relevant financial relationships to disclose at this time.
Reviewer(s)

Dorothy Caputo, MA BSN RN

has no relevant financial relationships to disclose at this time.

Rebecca Lakofsky, BSN, RN

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Hugh Auchincloss

has no relevant financial relationships to disclose at this time.

Haiquan Chen, MD. PhD.

has no relevant financial relationships to disclose at this time.

Erin Gillaspie

has a financial relationship (Advisor) with BMS;.
has a financial relationship (Advisor) with Intuitive Surgical;.
has a financial relationship (Advisor) with Genentech;.
has a financial relationship (Advisor) with Daiichi Sankyo;.
has a financial relationship (Advisor) with Merck;.
has a financial relationship (Speaker) with Astra Zeneca;.
has a financial relationship (Speaker) with BMS;.
has a financial relationship (Advisor) with Astra Zeneca;.

Erin Hoover, MD

has no relevant financial relationships to disclose at this time.

Dawn Jaroszewski, MD, MBA, FACS

has a financial relationship (Speaker) with Atricure, Inc;.
has a financial relationship (Consultant) with Zimmer Biomet Inc;.
has a financial relationship (Royalties or patent beneficiary) with Zimmer Biomet Inc;.

Siva Raja, MD, PhD

has no relevant financial relationships to disclose at this time.

Daniel Raymond, MD, FACS, FACCP

has a financial relationship (Individual stocks and stock options) with Bristol Myers Squibb;.
has a financial relationship (Consultant) with KLS Martin;.
has a financial relationship (Individual stocks and stock options) with Zimmer Biomet;.

Rishindra Reddy, MD, MBA

has a financial relationship (Advisor) with J&J;.
has a financial relationship (Advisor) with AZ;.
has a financial relationship (Consultant) with BMS;.
has a financial relationship (Advisor) with Genentech;.
has a financial relationship (Advisor) with Medtronic;.
has a financial relationship (Advisor) with Atricure;.
has a financial relationship (Advisor) with On Target Labs;.
has a financial relationship (Consultant) with Inuitive Surgical;.

James Reinersman, MD

has a financial relationship (Speaker) with Intuitive Surgical;.

Valerie Rusch, M.D.

has a financial relationship (Consultant) with American College of Surgeons;.

Sahar Saddoughi, M.D., Ph.D

has no relevant financial relationships to disclose at this time.

Christopher Seder, MD

has no relevant financial relationships to disclose at this time.

Dennis Wigle, MD

has no relevant financial relationships to disclose at this time.

Stephanie Worrell

has no relevant financial relationships to disclose at this time.

Stephen Yang, The Arthur B. and Patricia B. Modell Endowed Chair of Thoracic Surgery Vice Chair of Professional Development, Department of Surgery Professor of Surgery and Oncology The Johns Hopkins Medical Institutions Examination Chair Emeritus, and SESATS XIII Edito

has a financial relationship (Consultant) with ABTS;.

Crystal Zhang, MD, MPH

has no relevant financial relationships to disclose at this time.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and the General Thoracic Surgical Club. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 12.25 Interprofessional Continuing Education (IPCE) credit for learning and change.


Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 12.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 12.25 AAPA Category 1 CME
  • 12.25 AMA PRA Category 1 Credit
  • 12.25 Attendance

Price

Cost:
$0.00
Please login or register to take this course.